Research carried out with the participation of Maltese scientists into cases of women with ovarian cancer is yielding encouraging results. So far research has led to a treatment that has resulted in this type of cancer reducing by half in six days. More funds are required to complete research and development treatment.
Duncan Ayers from the University of Malta said that there are also good prospects for breast cancer and nerve cancer in children.
Maltese researchers are working hard to discover a new treatment designed for female patients who have an ovarian cancer recurrence.
Researcher Duncan Ayers explained that in these cases, the tumour would not have completely disappeared from their bodies also because they body has become resistant to the chemotherapy. Dr. Ayers’ research however seems to be finding a solution to this through a combination of chemotherapy and cancer genetic factors, known as microRNAs.
“In our studies we reduced the size of the tumor by 50% with a six-day treatment, ie we reduced the tumor by half in six days.”
This formula has been found to also work on breast cancer and nerve cancer in children.
In cancer tumors and even neuroblastoma in the levels of experiments we have done so far, we have even found that the size of the tumor decreases by 70% so far.
Dr Ayers said that the research costs thousands so much so that half a million euros have been spent so far since he started working on it 10 years ago. He warned that this research could end up without financial support.
Donations of 50c or € 1: If everyone in Malta manages to give a donation to the Alive Charity Foundation we would be in a fantastic position.
The research is being carried out in collaboration with the University of Ghent in Belgium.